Results 181 to 190 of about 17,904 (252)

Large‐Scale Evaluation of Traditional Chinese Medicines Reveals Potential PPARγ Modulators for Type 2 Diabetes Management

Journal of Clinical Laboratory Analysis, EarlyView.
Identifying novel treatments for diabetic management is always a competitive research topic all over the world. PPAR‐γ is one of the key regulators involved in glucose and lipid metabolism and improves insulin sensitivity and glucose homeostasis. This study investigated the impacts of 639 traditional Chinese medicine (TCM) on PPAR‐γ gene promoter ...
Mingyuan Dou, Shandra Jones, Juan Montes, Jonathan Ritter, Li‐Yu Shih, Chia‐Jung Chan, Ying‐Chou Lin, Min Chen, Shih‐Yin Chen, Ning Wu   +9 more
wiley   +1 more source

c-di-GMP does not bind H-NS, nor inhibits H-NS binding DNA. [PDF]

Nat Commun
Wang J, Wei H, Xia B.
europepmc   +1 more source

CO2 capture by accelerated weathering of limestone using waste limestone at elevated CO2 concentrations

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKGROUND Accelerated weathering of limestone (AWL) using waste limestone (WL) for industrially relevant CO2 capture remains underexplored. Previous studies on potable water‐operated AWL have mainly examined idealised conditions, such as the use of high‐purity limestone or relatively low CO2 concentrations, which may not reflect selected ...
Daniel Nyuin Alfred Damu, Alvin Guo Jian Lee, Slyvester Yew Wang Chai, Lock Hei Ngu   +3 more
wiley   +1 more source

Spatio-genetically coordinated TPR domain-containing proteins modulate c-di-GMP signaling in Vibrio vulnificus. [PDF]

PLoS Pathog
Mustaree S, Podicheti R, Rusch D, Rowe-Magnus DA.   +3 more
europepmc   +1 more source

Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta‐Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The transplantation of homogenous cells has emerged as an investigational strategy for Parkinson's disease (PD), offering an alternative to symptomatic treatment. Objective We performed a systematic review and meta‐analysis to assess its clinical efficacy and safety.
Nolan Reinisch, Athena Mancini, Adham Elsherbini, Jason Yuen, Andres Lozano   +4 more
wiley   +1 more source

Biofilm Dispersal in <i>Bacillus velezensis</i> FZB42 Is Regulated by the Second Messenger c-di-GMP. [PDF]

Microorganisms
Zhang M, Wu S, Chen P, Shao L, Shen Z, Zhao Y.   +5 more
europepmc   +1 more source

Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels, Gregory M. Pontone, Kuhan Pushparatnam, Indu Subramanian   +3 more
wiley   +1 more source

Perspective: Depression in Persons with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens, Gregory M. Pontone   +1 more
wiley   +1 more source

Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations

Movement Disorders, EarlyView.
Abstract Background Spastic paresis, resulting from central nervous system lesions, significantly impairs functional performance. In the framework of the International Classification of Functioning, Disability, and Health, functional performance was defined as functioning at the activity level in relation to the impairment of body functions and ...
Martina Hoskovcova, Marjolaine Baude, Bo Biering‐Sørensen, Ota Gal, Mary P Galea, Jean‐Michel Gracies, Carmen Rodriguez‐Blazquez, Theodore Wein, Michelle Hyczy de Siqueira Tosin, Álvaro Sánchez‐Ferro, Tiago A Mestre, Matej Skorvanek, Robert Jech, The members of the MDS Clinical Outcome Assessments Scientific Evaluation Committee and MDS Spasticity Study Group   +13 more
wiley   +1 more source

A novel two-component system contributing the catabolism of c-di-GMP influences virulence in Aeromonas veronii. [PDF]

Front Microbiol
Liu C, Shao J, Ma X, Tang Y, Li J, Li H, Chi X, Liu Z.   +7 more
europepmc   +1 more source